general-medicine
PREDICT Breast Cancer 5- and 10-year Survival (Bands)
PREDICT v3 (2024) is a Cambridge online tool estimating absolute benefit of adjuvant chemotherapy / endocrine / trastuzumab / bisphosphonates / chemo+olaparib (BRCA) in early breast cancer. This calc lets you record the calculated 10-year overall survival band and treatment recommendation summary. Always run the live tool at predict.nhs.uk for individualised numbers.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Ianalumab (Anti-BAFF — Primary Sjögren's Syndrome) · Anti-BAFF Monoclonal Antibody (B-Cell Survival Factor Inhibitor)
- Dalteparin · Low Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.